CymitQuimica logo

CAS 257879-35-9

:

Formule :C24H21N5O2
InChI :InChI=1S/C24H21N5O2/c30-23-21(22(24(31)27-23)26-17-7-2-1-3-8-17)19-15-29(20-10-5-4-9-18(19)20)13-6-12-28-14-11-25-16-28/h1-5,7-11,14-16H,6,12-13H2,(H2,26,27,30,31)
Code InChI :KIWODJBCHRADND-UHFFFAOYSA-N
SMILES :C1=CC=C(C=C1)NC2=C(C(=O)NC2=O)C3=CN(C4=CC=CC=C43)CCCN5C=CN=C5
7 produits trouvés.
  • PKCβ Inhibitor

    CAS :
    Formule :C24H21N5O2
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :411.4558

    Ref: IN-DA01G83B

    250mg
    À demander
    5mg
    243,00€
    25mg
    298,00€
    100mg
    524,00€
  • PKCβ inhibitor 1

    CAS :
    PKCβ inhibitor 1
    Formule :C24H21N5O2
    Degré de pureté :≥98%
    Masse moléculaire :411.46

    Ref: 54-BUP04701

    1mg
    71,00€
    5mg
    156,00€
    10mg
    267,00€
    25mg
    553,00€
    50mg
    967,00€
    100mg
    1.219,00€
  • PKCβ inhibitor 1

    CAS :
    PKCβ inhibitor 1 (KUN79359)(KUN79359) is a potent, selective and ATP-competitive inhibitor of PKC isozymes(IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2,
    Formule :C24H21N5O2
    Degré de pureté :99.33%
    Couleur et forme :Yellow Solid
    Masse moléculaire :411.4558
  • PKCβ inhibitor 1

    CAS :
    3-(1-(3-(1H-Imidazol-1-yl)propyl)-1H-indol-3-yl)-4-(phenylamino)-1H-pyrrole-2,5-dione
    Formule :C24H21N5O2
    Degré de pureté :98%
    Masse moléculaire :411.46
  • 3-(1-(3-IMIDAZOL-1-YLPROPYL)-1H-INDOL-3-YL)-4-ANILINO-1H-PYRROLE-2,5-DIONE

    CAS :
    Degré de pureté :98%
    Masse moléculaire :411.4649963

    Ref: 10-F844432

    25mg
    361,00€
    100mg
    736,00€
    250mg
    1.435,00€
  • 3-Anilino-4-[1-(3-imidazol-1-ylpropyl)indol-3-yl]pyrrole-2,5-dione

    Produit contrôlé
    CAS :
    Formule :C24H21N5O2
    Couleur et forme :Neat
    Masse moléculaire :411.456

    Ref: TR-A433470

    250mg
    4.761,00€
  • PKC² inhibitor 1

    CAS :

    PKC2 inhibitor 1 is a small molecule that inhibits the PKC2 signaling pathway. It has been shown to reduce the severity of diabetic neuropathy in mice by inhibiting cell death and neuronal degeneration. PKC2 inhibitor 1 also decreased atherosclerotic lesion formation in a pharmacological model of an experimental mouse. This drug can be used to treat congestive heart failure, locomotor activity, and autoimmune diseases such as type I diabetes mellitus.

    Formule :C24H21N5O2
    Degré de pureté :Min. 95%
    Masse moléculaire :411.46 g/mol

    Ref: 3D-HKA87935

    10mg
    781,00€
    25mg
    1.380,00€
    50mg
    1.920,00€
    100mg
    2.993,00€